Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)

NCT04832880 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Baricitinib Oral Tablet [Olumiant]
DRUG: Remdesivir
DRUG: Dexamethasone

Sponsor

ASST Fatebenefratelli Sacco